Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aptamer Group Plc (GB:APTA)
LSE:APTA
RESEARCH TOOLSreports
Holding GB:APTA?
Track your performance easily
APTA Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.20p - 1.40p
Previous Close0.35p
Volume16.58M
Average Volume (3M)18.12M
Market Cap
£6.96M
Enterprise Value7.80M
Total Cash (Recent Filing)£234.00K
Total Debt (Recent Filing)£1.08M
Price to Earnings (P/E)―
Beta1.92
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,920,000,000
10 Day Avg. Volume23,360,745
30 Day Avg. Volume18,120,832
Standard Deviation0.24
R-Squared0.06
Alpha-0.13
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)2.68
Price to Cash Flow (P/CF)-1.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aptamer Group Plc News
PremiumCompany Announcements
Aptamer Group’s CSO Increases Stake Signaling Confidence in Future
PremiumCompany Announcements
Aptamer Group Signs Key Development Contract in Life Sciences
PremiumCompany Announcements
Aptamer Group PLC Announces Change in Voting Rights Structure
PremiumCompany Announcements
Aptamer Group Director Increases Stake with Share Purchase
PremiumCompany Announcements
Aptamer Group Announces Change in Major Shareholder Holdings
PremiumCompany Announcements
Pathcelerate Limited Acquires Significant Stake in Aptamer Group PlcPremiumCompany Announcements
Aptamer Group CEO Boosts Stake with Share PurchasePremiumCompany Announcements
Aptamer Group Plc Issues New Options to Boost GrowthOptions Prices
Currently, No data available
---
Ownership Overview
APTA FAQ
What was Aptamer Group Plc’s price range in the past 12 months?
Aptamer Group Plc lowest share price was 0.20p and its highest was 1.40p in the past 12 months.
What is Aptamer Group Plc’s market cap?
Currently, no data Available
When is Aptamer Group Plc’s upcoming earnings report date?
Aptamer Group Plc’s upcoming earnings report date is Mar 27, 2025 which is in 95 days.
How were Aptamer Group Plc’s earnings last quarter?
Aptamer Group Plc released its earnings results on Oct 22, 2024. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
Is Aptamer Group Plc overvalued?
According to Wall Street analysts Aptamer Group Plc’s price is currently Overvalued.
Does Aptamer Group Plc pay dividends?
Aptamer Group Plc does not currently pay dividends.
What is Aptamer Group Plc’s EPS estimate?
Aptamer Group Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aptamer Group Plc have?
Aptamer Group Plc has 1,987,843,600 shares outstanding.
What happened to Aptamer Group Plc’s price movement after its last earnings report?
Aptamer Group Plc reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aptamer Group Plc?
Currently, no hedge funds are holding shares in GB:APTA
---
Aptamer Group Plc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth £80.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.83%
12-Months-Change
Fundamentals
Return on Equity
-496.73%
Trailing 12-Months
Asset Growth
0.58%
Trailing 12-Months
Company Description
Aptamer Group Plc
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.
---
Technical Analysis
---